Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23045618 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed Influenza
Condition: Influenza
Interventions: Drug: DAS181 dry powder, formulation F02;   Drug: Respitose ML006 (DMV-Fonterra)

Indicates status has not been verified in more than two years